SgRNA for beta-hemoglobinopathy gene editing and application
A technology for hemoglobinopathies and gene editing, which is applied to the sgRNA and application fields of gene editing for β-hemoglobinopathies, can solve the problems of high cost and low editing efficiency, and achieve the effects of cost reduction, improved gene editing efficiency, and improved gene editing efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0038] The core sequence of BCL11A gene enhancer in 293FT cells was mutated by CRISPR-Sp Cas9 technology.
[0039] 1. Construct the sgRNA-spCas9 vector with optimized sgRNA structure.
[0040] On the basis of the sgRNA-spCas9 vector (PX459) we used, the original sgRNA expression cassette was replaced with a structurally optimized sgRNA expression cassette (such as figure 1 shown), to obtain the PX459-OP vector (attached figure 2 ), the base pairing number of the first complementary structural domain and the second complementary structural domain is increased to 16, and the sgRNA expressed by it contains SEQ ID NO: 1 (5'- UGCUG-3') or its antisense complementary sequence (5'-CAGCA-3').
[0041] The specific operation process is as follows:
[0042] 1) Using the PX459 carrier DNA as a template, using the sequences in the table below such as SEQ ID NO:7 and DNA of SEQ ID NO:10 as primers, PCR amplification to obtain product 1 (324bp), using the sequences in the table below su...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com